Basic Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Dec 14, 2015; 21(46): 13030-13041
Published online Dec 14, 2015. doi: 10.3748/wjg.v21.i46.13030
Figure 6
Figure 6 Silencing of Yes1 reduces proliferation of hepatocellular carcinoma cells. HuH7 cells were untreated (UT), or mock transfected with Lipofectamine 2000 (Mock), or transfected with either siRNA negative control (Neg) or siRNA targeting Yes1 (siY). Cell proliferation was determined using the MTS assay. Data shown represent mean ± SD (n = 4). aP < 0.05, Student’s t-test analysis for comparison to mock treatment.